These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 35909315)

  • 1. p38α-MAPK-deficient myeloid cells ameliorate symptoms and pathology of APP-transgenic Alzheimer's disease mice.
    Luo Q; Schnöder L; Hao W; Litzenburger K; Decker Y; Tomic I; Menger MD; Liu Y; Fassbender K
    Aging Cell; 2022 Aug; 21(8):e13679. PubMed ID: 35909315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal deficiency of p38α-MAPK ameliorates symptoms and pathology of APP or Tau-transgenic Alzheimer's mouse models.
    Schnöder L; Gasparoni G; Nordström K; Schottek A; Tomic I; Christmann A; Schäfer KH; Menger MD; Walter J; Fassbender K; Liu Y
    FASEB J; 2020 Jul; 34(7):9628-9649. PubMed ID: 32475008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Alzheimer's disease brain pathology in mice by gut bacterial depletion: the role of IL-17a.
    Hao W; Luo Q; Tomic I; Quan W; Hartmann T; Menger MD; Fassbender K; Liu Y
    Gut Microbes; 2024; 16(1):2363014. PubMed ID: 38904096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploinsufficiency of microglial MyD88 ameliorates Alzheimer's pathology and vascular disorders in APP/PS1-transgenic mice.
    Quan W; Luo Q; Hao W; Tomic I; Furihata T; Schulz-Schäffer W; Menger MD; Fassbender K; Liu Y
    Glia; 2021 Aug; 69(8):1987-2005. PubMed ID: 33934399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
    CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse.
    Gee MS; Son SH; Jeon SH; Do J; Kim N; Ju YJ; Lee SJ; Chung EK; Inn KS; Kim NJ; Lee JK
    Alzheimers Res Ther; 2020 Apr; 12(1):45. PubMed ID: 32317025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ).
    Bachstetter AD; Xing B; de Almeida L; Dimayuga ER; Watterson DM; Van Eldik LJ
    J Neuroinflammation; 2011 Jul; 8():79. PubMed ID: 21733175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P38α-MAPK phosphorylates Snapin and reduces Snapin-mediated BACE1 transportation in APP-transgenic mice.
    Schnöder L; Tomic I; Schwindt L; Helm D; Rettel M; Schulz-Schaeffer W; Krause E; Rettig J; Fassbender K; Liu Y
    FASEB J; 2021 Jul; 35(7):e21691. PubMed ID: 34118085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IKKβ deficiency in myeloid cells ameliorates Alzheimer's disease-related symptoms and pathology.
    Liu Y; Liu X; Hao W; Decker Y; Schomburg R; Fülöp L; Pasparakis M; Menger MD; Fassbender K
    J Neurosci; 2014 Sep; 34(39):12982-99. PubMed ID: 25253847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid Arginase 1 Insufficiency Exacerbates Amyloid-β Associated Neurodegenerative Pathways and Glial Signatures in a Mouse Model of Alzheimer's Disease: A Targeted Transcriptome Analysis.
    Ma C; Hunt JB; Kovalenko A; Liang H; Selenica MB; Orr MB; Zhang B; Gensel JC; Feola DJ; Gordon MN; Morgan D; Bickford PC; Lee DC
    Front Immunol; 2021; 12():628156. PubMed ID: 34046031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.
    Maier M; Peng Y; Jiang L; Seabrook TJ; Carroll MC; Lemere CA
    J Neurosci; 2008 Jun; 28(25):6333-41. PubMed ID: 18562603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early chronic suppression of microglial p38α in a model of Alzheimer's disease does not significantly alter amyloid-associated neuropathology.
    Braun DJ; Frazier HN; Davis VA; Coleman MJ; Rogers CB; Van Eldik LJ
    PLoS One; 2023; 18(5):e0286495. PubMed ID: 37256881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
    Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
    J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner.
    Lecordier S; Pons V; Rivest S; ElAli A
    Front Immunol; 2021; 12():813536. PubMed ID: 35173711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease pathology is attenuated in a CD38-deficient mouse model.
    Blacher E; Dadali T; Bespalko A; Haupenthal VJ; Grimm MO; Hartmann T; Lund FE; Stein R; Levy A
    Ann Neurol; 2015 Jul; 78(1):88-103. PubMed ID: 25893674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of Neuronal p38α MAPK Attenuates Amyloid Pathology in Alzheimer Disease Mouse and Cell Models through Facilitating Lysosomal Degradation of BACE1.
    Schnöder L; Hao W; Qin Y; Liu S; Tomic I; Liu X; Fassbender K; Liu Y
    J Biol Chem; 2016 Jan; 291(5):2067-79. PubMed ID: 26663083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling.
    Li L; Wu XH; Zhao XJ; Xu L; Pan CL; Zhang ZY
    J Neuroinflammation; 2020 Feb; 17(1):61. PubMed ID: 32066466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
    Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H
    J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.